• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体内实验大鼠胶质瘤模型中体积倍增时间和细胞丢失的估计

Estimation of volume doubling time and cell loss in an experimental rat glioma model in vivo.

作者信息

Nakajima M, Nakasu S, Morikawa S, Inubushi T

机构信息

Department of Neurosurgery, Shiga University of Medical Science, Japan.

出版信息

Acta Neurochir (Wien). 1998;140(6):607-12; discussion 612-3. doi: 10.1007/s007010050148.

DOI:10.1007/s007010050148
PMID:9755330
Abstract

We estimated the volume doubling time (Vd) of the ethyl-nitrosourea-induced rat glioma by serial magnetic resonance imaging, and the results were compared with potential doubling time (Tp) determined immunohistochemically. Vd ranged from 3.3 to 29.2 days (11.3 +/- 7.74) and Tp ranged from 2.3 to 13.3 days (6.81 +/- 3.33). Each tumour showed a wide range of bromodeoxyuridine (BUdR) labelling indices (LI), however, Vd and Tp correlated well with BUdR-LI. Vd was estimated as 17.6 x BUdR-LI-0.63 (R = -0.76, P < 0.001, n = 13) and Tp was estimated as 22.6 x BUdR-LI-1.02 (R = -0.92, P < 0.0001, n = 12). In addition, we compared the apoptotic indices (AI), determined by terminal deoxynucleotidyltransferase (Tdt)-mediated biotinylated dUTP-biotin nick-end labelling (TUNEL) techniques, with BUdR-LI and mitoses indices (MI). The results were: AI = 0.23 + 0.25Ln(BUdR-LI) (R = 0.971, n = 8, P < 0.0001) and AI = 1.05 + 0.29Ln(MI) (R = 0.937, n = 8, P < 0.001). Cell loss factors (CLF) also correlated well with BUdR-LI and MI. However, CLF calculated from Tp and Vd were lower than the values previously presumed, probably because of shorter Vd than true doubling time for tumour cell population. These results suggest that even malignant tumours retain a mechanism of adjusting their growth at least partly.

摘要

我们通过连续磁共振成像估计了乙基亚硝基脲诱导的大鼠胶质瘤的体积倍增时间(Vd),并将结果与免疫组织化学测定的潜在倍增时间(Tp)进行比较。Vd范围为3.3至29.2天(11.3±7.74),Tp范围为2.3至13.3天(6.81±3.33)。每个肿瘤的溴脱氧尿苷(BUdR)标记指数(LI)范围广泛,然而,Vd和Tp与BUdR-LI密切相关。Vd估计为17.6×BUdR-LI-0.63(R = -0.76,P < 0.001,n = 13),Tp估计为22.6×BUdR-LI-1.02(R = -0.92,P < 0.0001,n = 12)。此外,我们将通过末端脱氧核苷酸转移酶(Tdt)介导的生物素化dUTP-生物素缺口末端标记(TUNEL)技术测定的凋亡指数(AI)与BUdR-LI和有丝分裂指数(MI)进行比较。结果为:AI = 0.23 + 0.25Ln(BUdR-LI)(R = 0.971,n = 8,P < 0.0001)和AI = 1.05 + 0.29Ln(MI)(R = 0.937,n = 8,P < 0.001)。细胞丢失因子(CLF)也与BUdR-LI和MI密切相关。然而,根据Tp和Vd计算的CLF低于先前推测的值,可能是因为Vd比肿瘤细胞群体的真正倍增时间短。这些结果表明,即使是恶性肿瘤也至少部分保留了调节其生长的机制。

相似文献

1
Estimation of volume doubling time and cell loss in an experimental rat glioma model in vivo.体内实验大鼠胶质瘤模型中体积倍增时间和细胞丢失的估计
Acta Neurochir (Wien). 1998;140(6):607-12; discussion 612-3. doi: 10.1007/s007010050148.
2
Cell kinetic analysis of human brain tumors by in situ double labelling with bromodeoxyuridine and iododeoxyuridine.
Int J Cancer. 1992 Jan 2;50(1):1-5. doi: 10.1002/ijc.2910500102.
3
Cell kinetics of rat 9L brain tumors determined by double labeling with iodo- and bromodeoxyuridine.通过碘脱氧尿苷和溴脱氧尿苷双重标记法测定大鼠9L脑肿瘤的细胞动力学
J Neurosurg. 1990 Aug;73(2):254-8. doi: 10.3171/jns.1990.73.2.0254.
4
Cell kinetics of glial tumors.胶质细胞瘤的细胞动力学
Rev Neurol (Paris). 1992;148(6-7):396-401.
5
[Proliferation kinetics of human brain tumors by in situ double labeling with bromodeoxyuridine and iododeoxyuridine].
No To Shinkei. 1992 Sep;44(9):821-5.
6
Correlation of histopathological features and proliferative potential of gliomas.
J Neurosurg. 1989 May;70(5):701-6. doi: 10.3171/jns.1989.70.5.0701.
7
Prognostic significance of the proliferative potential of intracranial gliomas measured by bromodeoxyuridine labeling.通过溴脱氧尿苷标记测量的颅内胶质瘤增殖潜能的预后意义。
Int J Cancer. 1993 Feb 20;53(4):550-5. doi: 10.1002/ijc.2910530404.
8
Correlation between the bromodeoxyuridine labeling index and the MIB-1 and Ki-67 proliferating cell indices in cerebral gliomas.脑胶质瘤中溴脱氧尿苷标记指数与MIB-1和Ki-67增殖细胞指数之间的相关性
Cancer. 1994 Oct 1;74(7):1921-6. doi: 10.1002/1097-0142(19941001)74:7<1921::aid-cncr2820740716>3.0.co;2-9.
9
A new method for analyzing the cell kinetics of human brain tumors by double labeling with bromodeoxyuridine in situ and with iododeoxyuridine in vitro.一种通过溴脱氧尿苷原位双标记和碘脱氧尿苷体外双标记分析人脑肿瘤细胞动力学的新方法。
Cancer. 1993 May 15;71(10):3109-13. doi: 10.1002/1097-0142(19930515)71:10<3109::aid-cncr2820711035>3.0.co;2-f.
10
Proliferative potential of recurrent intracranial meningiomas as evaluated by labelling indices of BUdR and Ki-67, and tumour doubling time.通过溴脱氧尿苷(BUdR)和Ki-67标记指数以及肿瘤倍增时间评估复发性颅内脑膜瘤的增殖潜能。
Acta Neurochir (Wien). 1998;140(1):26-31; discussion 31-2. doi: 10.1007/s007010050053.

引用本文的文献

1
Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma.抗血管内皮生长因子治疗减少胶质母细胞瘤的血液供应并增加肿瘤细胞浸润。
Proc Natl Acad Sci U S A. 2011 Mar 1;108(9):3749-54. doi: 10.1073/pnas.1014480108. Epub 2011 Feb 14.
2
Introduction of hypermatrix and operator notation into a discrete mathematics simulation model of malignant tumour response to therapeutic schemes in vivo. Some operator properties.将超矩阵和算子符号引入体内恶性肿瘤对治疗方案反应的离散数学模拟模型。一些算子性质。
Cancer Inform. 2009 Oct 21;7:239-51. doi: 10.4137/cin.s2712.
3
Critical parameters determining standard radiotherapy treatment outcome for glioblastoma multiforme: a computer simulation.
决定多形性胶质母细胞瘤标准放射治疗结果的关键参数:计算机模拟
Open Biomed Eng J. 2008 Sep 10;2:43-51. doi: 10.2174/1874120700802010043.
4
Magnetic resonance imaging of ethyl-nitrosourea-induced rat gliomas: a model for experimental therapeutics of low-grade gliomas.乙基亚硝基脲诱导的大鼠胶质瘤的磁共振成像:一种低级别胶质瘤实验性治疗的模型
J Neurooncol. 2001 Jul;53(3):243-57. doi: 10.1023/a:1012222522359.